Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1987-3-30
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0232-7295
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
367-70
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3825216-Antibody-Dependent Cell Cytotoxicity,
pubmed-meshheading:3825216-Bilirubin,
pubmed-meshheading:3825216-Granulocytes,
pubmed-meshheading:3825216-Humans,
pubmed-meshheading:3825216-Immunosuppression,
pubmed-meshheading:3825216-Lymphocytes,
pubmed-meshheading:3825216-Monocytes,
pubmed-meshheading:3825216-Nifedipine,
pubmed-meshheading:3825216-Transplantation
|
pubmed:year |
1986
|
pubmed:articleTitle |
[Differentiated pharmacologic modification of cytotoxic effector mechanisms].
|
pubmed:publicationType |
Journal Article
|